DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162522

A study of thyroid dysfunction in HIV infected patients in a tertiary care hospital

Mala V. Kaneria, Vinit V. Kahalekar

Abstract


Background: Increasing prevalence of thyroid dysfunction has been reported in HIV-infected patients. However, there is insufficient evidence to recommend routine thyroid screening of asymptomatic individuals. Hence, this study was undertaken in an attempt to resolve these issues.

Methods: A cross sectional prevalence study was conducted on 75 adult HIV positive patients who did not suffer from hypertension, diabetes, coronary artery disease or thyroid disorder. A detailed history taking and examination was done and biochemical, microbiological and radiological tests were performed in order to reach a diagnosis. In addition, FT3, FT4, TSH and CD4 were done in all the patients.

Results: Overt hypothyroidism was found in 2 (3%), subclinical hypothyroidism in 10 (13%), isolated low FT4  in 2 (3%)  and sick euthyroidism in 19 (25%) patients. As the stage of HIV advanced, the FT3 and FT4 levels went on decreasing. The TSH levels however, did not correlate with the stage of infection. A direct correlation was found between FT3 and CD4 counts and an inverse correlation between TSH levels and CD4 counts. The mean TSH levels in patients on HAART were significantly higher than in patients not on HAART. Cryptococcal meningitis was found to be associated with subclinical hypothyroidism, CNS toxoplasmosis with isolated low FT4 levels and tuberculosis with sick euthyroidism.

Conclusions: Thyroid dysfunction in HIV infected patients was largely asymptomatic. There was a direct correlation between WHO clinical stage of infection and serum FT3 and FT4 levels. TSH levels increased as CD4 counts decreased. Patients on HAART had a high prevalence of subclinical hypothyroidism. No association could be implied between opportunistic infections (OIs) and thyroid dysfunction, due to a small sample size.

Keywords


Thyroid dysfunction, HIV, Sick euthyroidism, Subclinical hypothyroidism

Full Text:

PDF

References


Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis. 2003;37:579-83.

Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy.Clin Endocrinol (Oxf) . 2006;64:375-83.

Hoffman CJ, Brown TT. Thyroid Function Abnormalities in HIV-Infected Patients Clin Infect Dis. 2007;45(4):488-94.

Calza L, Manfredi R, Chiodo F. “Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy,” Journal of Acquired Immune Deficiency Syndromes. 2002;31(3):361-3.

Pearce EN. Diagnosis management of thyrotoxicosis. BMJ. 2006;332:1369-73.

Sharma N, Sharma LK, Dutta D, Gadpayle AK, Anand A, Gaurav K, et al. “Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective,” Journal of Thyroid Research. 2015(2015).

Raffi F, Brisseau JM, Planchon B, Rémi JP, Barrier JH, Grolleau JY. Endocrine function in 98 HIV-infected patients: a prospective study. AIDS. 1991;5:729-33.

Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 1990;70:566-71.

Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646-55.

Collazos J, Ibarra S, Mayo J Thyroid hormones in HIV infected patients in the highly active antiretroviral therapy era: evidence of an interrelationship between the thyroid axis and the immune system. AIDS. 2003:17:763-5.

Quirino T, Bongiovanni M, Ricci E. Hypothyroidism in HIV infected patients who have or have not received HAART. Clin Infect Disease. 2004:38:596-7.

Madge S, Smith C, Lampe F, et al: No association between HIV disease and its treatment and thyroid function. British HIV Association HIV Medicine 2007;8:22-7.

Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS. 2000;14:1070-2.

Jain G, Devpura G, Gupta BS. Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults. JAPI. 2009;57:508-10.

Vigano A, Riboni S, Bianchi R. Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J. 2004;23:235-9.

Varthakavi P. Thyroid Dysfunction in HIV-AIDS. JAPI. 2009;57:503-4.

Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis. 2004;38:1159-66.

Battegay M, Drechsler H. Clinical spectrum of the immune restoration inflammatory syndrome. Curr Opin HIV AIDS. 2006;1:56-61.